Gene Therapy for Neurological Disorders

Rishabha Malviya, PhD, is an Associate Professor of Pharmacy at the School of Medical and Allied Sciences, Galgotias University, Uttar Pradesh, India. He has authored more than 150 research and review papers for national and international journals of repute and has edited 13 books. He holds over 50 patents. Listed in the World’s Top 2% Scientists list by Elsevier BV and Stanford University, he is a reviewer, editor, and editorial board member of more than 50 national and international journals.Arun Kumar Singh, MPharm, is affiliated with the Department of Pharmacy, School of Medical & Allied Sciences, Galgotias University, Uttar Pradesh, India. His areas of interest include nanoformulation, blockchain, IoT, machine learning, cancer, artificial intelligence, and big data. He has published several book chapters in the field of big data as well as review papers. Priyanshi Goyal, MPharm, is affiliated with the Department of Pharmacy at the School of Medical and Allied Sciences, Galgotias University, Uttar Pradesh India. She has authored a book chapter and is the author of one book from Apple Academic Press, Taylor and Francis Group. She earned her BPharm from Aligarh College of Pharmacy, Aligarh, affiliated with AKTU, Lucknow, and her MPharm from Galgotias University, Greater Noida, India.Sonali Sundram, MPharm, is an Assistant Professor in the School of Medical and Allied Sciences at Galgotias University, Greater Noida, Uttar Pradesh, India. Previously, she worked as a research scientist on a project of ICMR at King George’s Medical University, Lucknow, India; as well as at BBDNIIT (Babu Banarasi Das Northern India Institute of Technology), Lucknow. Her PhD (Pharmacy) work was in neurodegeneration and nanoformulation. She has edited four books and has organized more than 15 national and international seminars, conferences, and workshops. She has several patents, both national and international, to her credit.

• 1. Neurodegenerative Disorders and Their Treatment 2. Neurodegenerative Disorder: A Mysterious Group of Diseases 3. Propagation of Neurodegenerative disorders4. Gene Therapy: A Promising Strategy for the Treatment of Brain Disease 5. Stem-Cell-Employed Gene Therapy for Neurodegenerative Disorder 6. Current Practice and Prospects in Gene Therapy Based on Genomic DNA 7. Targeting Oligodendrocytes with Gene-Silencing Sequences through Vector-Mediated Transgene Delivery 8. Astrocytes: Genetic Treatment Targets for Alzheimer‘s Disease 9. Clinical Studies of Gene Therapy for the Treatment of Neurodegenerative Disorders